{"id":72362,"date":"2026-08-12T12:05:54","date_gmt":"2026-08-12T04:05:54","guid":{"rendered":"https:\/\/flcube.com\/?p=72362"},"modified":"2026-08-12T12:05:56","modified_gmt":"2026-08-12T04:05:56","slug":"haohai-wins-nmpa-approval-for-chinas-first-domestic-trifocal-toric-intraocular-lens-for-cataract-patients-with-astigmatism","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72362","title":{"rendered":"Haohai Wins NMPA Approval for China&#8217;s First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Shanghai Haohai Biological Technology Co. Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/688366:SHA\">SHA: 688366<\/a>) announced that its <strong>trifocal toric intraocular lens (IOL)<\/strong> has been <strong>approved by the National Medical Products Administration (NMPA) for market launch<\/strong>. The product is indicated for <strong>visual correction in adult aphakic patients with cataracts and corneal astigmatism<\/strong>, aiming to <strong>correct corneal astigmatism while improving near, intermediate, and distance vision<\/strong> and <strong>reducing spectacle dependency<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-approval-overview\" class=\"wp-block-heading\">Approval Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366)<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>Trifocal toric intraocular lens (IOL)<\/td><\/tr><tr><td><strong>Regulatory Agency<\/strong><\/td><td>NMPA (China)<\/td><\/tr><tr><td><strong>Approval Pathway<\/strong><\/td><td>National special approval procedure for innovative medical devices<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Visual correction in adult aphakic patients with cataracts and corneal astigmatism<\/td><\/tr><tr><td><strong>Market Status<\/strong><\/td><td>First domestic trifocal toric IOL approved in China<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>7 Aug 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-product-profile-amp-technology\" class=\"wp-block-heading\">Product Profile &amp; Technology<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Innovation:<\/strong> The product <strong>innovatively combines a trifocal diffractive optical design with toric astigmatism correction technology<\/strong> \u2014 a first among domestically developed IOLs in China.<\/li>\n\n\n\n<li><strong>Dual Function:<\/strong> It <strong>effectively corrects corneal astigmatism<\/strong> while <strong>enhancing patients&#8217; full\u2011range vision \u2014 near, intermediate, and distance<\/strong> \u2014 providing a more comprehensive visual solution for cataract patients with corneal astigmatism.<\/li>\n\n\n\n<li><strong>Clinical Benefit:<\/strong> Designed to <strong>reduce spectacle dependency<\/strong>, addressing the quality\u2011of\u2011life expectations of an increasingly demanding cataract surgery population.<\/li>\n\n\n\n<li><strong>Regulatory Significance:<\/strong> Approved through the <strong>national special approval procedure for innovative medical devices<\/strong>, underscoring its designation as a breakthrough domestic device.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Import Substitution:<\/strong> Premium multifocal and toric IOLs in China have been dominated by multinational suppliers \u2014 this approval makes Haohai the <strong>first domestic player<\/strong> in the trifocal toric segment, a milestone for China&#8217;s high\u2011end ophthalmic device industry.<\/li>\n\n\n\n<li><strong>Large Addressable Base:<\/strong> China performs tens of millions of cataract surgeries annually, and corneal astigmatism affects a substantial share of cataract patients, making astigmatism\u2011correcting premium IOLs one of the fastest\u2011growing niches in ophthalmology.<\/li>\n\n\n\n<li><strong>Premiumization Trend:<\/strong> As patients increasingly seek spectacle independence after cataract surgery, trifocal toric IOLs command premium pricing and represent the highest\u2011value tier of the IOL market.<\/li>\n\n\n\n<li><strong>Competitive Positioning:<\/strong> First\u2011mover status in the domestic segment gives Haohai a pricing and tender advantage against imported alternatives in China&#8217;s hospital procurement system.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding commercialization plans and market adoption for Haohai&#8217;s trifocal toric IOL. Actual results may differ due to risks including hospital procurement dynamics, competitive responses, and surgeon adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/688366_20260807_MD10.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 688366_20260807_MD10.\"><\/object><a id=\"wp-block-file--media-86a056d5-7b41-4c9b-82e4-ed859b92e246\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/688366_20260807_MD10.pdf\">688366_20260807_MD10<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/688366_20260807_MD10.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-86a056d5-7b41-4c9b-82e4-ed859b92e246\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366) announced that its trifocal toric intraocular lens&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,22],"tags":[4199,15,1264],"class_list":["post-72362","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-haohai-biological-technology","tag-product-approvals","tag-sha-688366"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Haohai Wins NMPA Approval for China&#039;s First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366) announced that its trifocal toric intraocular lens (IOL) has been approved by the National Medical Products Administration (NMPA) for market launch. The product is indicated for visual correction in adult aphakic patients with cataracts and corneal astigmatism, aiming to correct corneal astigmatism while improving near, intermediate, and distance vision and reducing spectacle dependency.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72362\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Haohai Wins NMPA Approval for China&#039;s First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism\" \/>\n<meta property=\"og:description\" content=\"Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366) announced that its trifocal toric intraocular lens (IOL) has been approved by the National Medical Products Administration (NMPA) for market launch. The product is indicated for visual correction in adult aphakic patients with cataracts and corneal astigmatism, aiming to correct corneal astigmatism while improving near, intermediate, and distance vision and reducing spectacle dependency.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72362\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-12T04:05:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-12T04:05:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72362#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72362\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Haohai Wins NMPA Approval for China&#8217;s First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism\",\"datePublished\":\"2026-08-12T04:05:54+00:00\",\"dateModified\":\"2026-08-12T04:05:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72362\"},\"wordCount\":405,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Haohai Biological Technology\",\"Product approvals\",\"SHA: 688366\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72362#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72362\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72362\",\"name\":\"Haohai Wins NMPA Approval for China's First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-12T04:05:54+00:00\",\"dateModified\":\"2026-08-12T04:05:56+00:00\",\"description\":\"Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366) announced that its trifocal toric intraocular lens (IOL) has been approved by the National Medical Products Administration (NMPA) for market launch. The product is indicated for visual correction in adult aphakic patients with cataracts and corneal astigmatism, aiming to correct corneal astigmatism while improving near, intermediate, and distance vision and reducing spectacle dependency.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72362#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72362\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72362#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Haohai Wins NMPA Approval for China&#8217;s First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Haohai Wins NMPA Approval for China's First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism - Insight, China&#039;s Pharmaceutical Industry","description":"Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366) announced that its trifocal toric intraocular lens (IOL) has been approved by the National Medical Products Administration (NMPA) for market launch. The product is indicated for visual correction in adult aphakic patients with cataracts and corneal astigmatism, aiming to correct corneal astigmatism while improving near, intermediate, and distance vision and reducing spectacle dependency.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72362","og_locale":"en_US","og_type":"article","og_title":"Haohai Wins NMPA Approval for China's First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism","og_description":"Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366) announced that its trifocal toric intraocular lens (IOL) has been approved by the National Medical Products Administration (NMPA) for market launch. The product is indicated for visual correction in adult aphakic patients with cataracts and corneal astigmatism, aiming to correct corneal astigmatism while improving near, intermediate, and distance vision and reducing spectacle dependency.","og_url":"https:\/\/flcube.com\/?p=72362","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-12T04:05:54+00:00","article_modified_time":"2026-08-12T04:05:56+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72362#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72362"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Haohai Wins NMPA Approval for China&#8217;s First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism","datePublished":"2026-08-12T04:05:54+00:00","dateModified":"2026-08-12T04:05:56+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72362"},"wordCount":405,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Haohai Biological Technology","Product approvals","SHA: 688366"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72362#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72362","url":"https:\/\/flcube.com\/?p=72362","name":"Haohai Wins NMPA Approval for China's First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-12T04:05:54+00:00","dateModified":"2026-08-12T04:05:56+00:00","description":"Shanghai Haohai Biological Technology Co. Ltd. (SHA: 688366) announced that its trifocal toric intraocular lens (IOL) has been approved by the National Medical Products Administration (NMPA) for market launch. The product is indicated for visual correction in adult aphakic patients with cataracts and corneal astigmatism, aiming to correct corneal astigmatism while improving near, intermediate, and distance vision and reducing spectacle dependency.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72362#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72362"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72362#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Haohai Wins NMPA Approval for China&#8217;s First Domestic Trifocal Toric Intraocular Lens for Cataract Patients With Astigmatism"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72362","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72362"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72362\/revisions"}],"predecessor-version":[{"id":72364,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72362\/revisions\/72364"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}